BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R. Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p. Onco Targets Ther 2020;13:7773-83. [PMID: 32801783 DOI: 10.2147/OTT.S253936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo J, Wang S, Zhang L, Zhang L, Wu S, Zheng W, Huang X, Ye X, Wu M. Research advance and clinical implication of circZNF609 in human diseases. Biotechnology & Biotechnological Equipment 2022;36:668-683. [DOI: 10.1080/13102818.2022.2118076] [Reference Citation Analysis]
2 Zhang L, Xu T, Li Y, Pang Q, Ding X. Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma. J Clin Lab Anal 2022;:e24741. [PMID: 36268976 DOI: 10.1002/jcla.24741] [Reference Citation Analysis]
3 Wang S, Wu J, Wang Z, Gong Z, Liu Y, Wang Z. Emerging Roles of Circ-ZNF609 in Multiple Human Diseases. Front Genet 2022;13:837343. [DOI: 10.3389/fgene.2022.837343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi P, Liu Y, Yang D, Wu Y, Zhang L, Jing S, Shi H, Geng C. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered 2022;13:4372-84. [PMID: 35135416 DOI: 10.1080/21655979.2022.2033015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Zhang Y, Shao J, Li S, Liu Y, Zheng M. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma. Front Oncol 2021;11:775250. [PMID: 34804980 DOI: 10.3389/fonc.2021.775250] [Reference Citation Analysis]
6 Qian Y, Li Y, Li R, Yang T, Jia R, Ge YZ. circ-ZNF609: A potent circRNA in human cancers. J Cell Mol Med 2021;25:10349-61. [PMID: 34697887 DOI: 10.1111/jcmm.16996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cao J, Jiang M, Ren H, Xu K. MicroRNA‑200c‑3p suppresses intervertebral disc degeneration by targeting RAP2C/ERK signaling. Mol Med Rep 2021;24:865. [PMID: 34676879 DOI: 10.3892/mmr.2021.12505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu Q, Cui W, Yang C, Du LP. Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. Aging (Albany NY) 2021;13:19822-34. [PMID: 34370715 DOI: 10.18632/aging.203394] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Du S, Li H, Lu F, Zhang S, Tang J. Circular RNA ZNF609 promotes the malignant progression of glioma by regulating miR-1224-3p/PLK1 signaling. J Cancer 2021;12:3354-66. [PMID: 33976745 DOI: 10.7150/jca.54934] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
10 Gu Q, Hou W, Shi L, Liu H, Zhu Z, Ye W. Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression. Bioengineered 2021;12:927-36. [PMID: 33734009 DOI: 10.1080/21655979.2021.1896116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
11 Ely A, Bloom K, Maepa MB, Arbuthnot P. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1-17. [PMID: 33542907 DOI: 10.2147/JHC.S268291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]